iShares Trust - iShares Biotechnology ETF
GB ˙ LSE ˙ US4642875565
131,05 $ ↓ -0,77 (-0,58%)
2023-12-18
DEL PRIS
SecurityGB:0JGB / iShares Trust - iShares Biotechnology ETF
InstitutionKestra Private Wealth Services, Llc
Latest Disclosed Ownership7,176 shares
Latest Disclosed Value $ 1,211,714
Kestra Private Wealth Services, Llc reports 9.37% increase in ownership of 0JGB / iShares Trust - iShares Biotechnology ETF

On April 20, 2026 - Kestra Private Wealth Services, Llc filed a 13F-HR form disclosing ownership of 7,176 shares of iShares Trust - iShares Biotechnology ETF (GB:0JGB) valued at $1,211,714 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 29, 2026 disclosing 6,561 shares of iShares Trust - iShares Biotechnology ETF. This represents a change in shares of 9.37% during the quarter. The current value of the position is $940,415 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-04-20 2026-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 7,176 615 9.37 1,212 9.39 0.0149
2026-01-29 2025-12-31 13F ISHARES TR MORNINGSTAR VALU 464287556 6,561 349 5.62 1,107 23.55 0.0137
2025-11-17 2025-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 6,212 -600 -8.81 897 4.07 0.0117
2025-08-07 2025-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 6,812 278 4.25 862 3.11 0.0124
2025-05-05 2025-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 6,534 169 2.66 836 -0.71 0.0139
2025-01-28 2024-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 6,365 1,284 25.27 842 13.80 0.0143
2024-11-13 2024-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 5,081 552 12.19 740 19.00 0.0136
2024-08-12 2024-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 4,529 -461 -9.24 622 -9.21 0.0124
2024-05-02 2024-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 4,990 -451 -8.29 685 -7.44 0.0154
2024-02-05 2023-12-31 13F ISHARES TR MSCI AC ASIA ETF 464287556 5,441 -1,372 -20.14 739 -11.28 0.0189
2023-11-08 2023-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 6,813 -1,373 -16.77 833 -19.83 0.0262
2023-08-08 2023-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 8,186 -60 -0.73 1,039 -2.44 0.0356
2023-05-12 2023-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 8,246 208 2.59 1,065 0.95 0.0424
2023-02-01 2022-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 8,038 2,166 36.89 1,055 0.0535
2022-11-14 2022-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 5,872 134 2.34 1 0.0398
2022-08-12 2022-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 5,738 -557 -8.85 1 0.0385
2022-07-21 2022-03-31 13F/A-1 ISHARES TR ISHARES BIOTECH 464287556 6,295 279 4.64 1 -100.00 0.0407
2022-05-26 2022-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 6,295 279 820 0.0407
2022-07-21 2021-12-31 13F/A-1 ISHARES TR ISHARES BIOTECH 464287556 6,016 -911 -13.15 1 -100.00 0.0439
2022-01-21 2021-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 6,016 -911 918 0.0439
2022-07-26 2021-09-30 13F/A-1 ISHARES TR ISHARES BIOTECH 464287556 6,927 920 15.32 1 -99.90 0.0625
2021-10-21 2021-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 6,927 920 1,120 0.0625
2022-07-27 2021-06-30 13F/A-1 ISHARES TR ISHARES BIOTECH 464287556 6,007 913 17.92 1 -100.00 0.0598
2021-07-30 2021-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 6,007 913 983 0.0598
2022-07-27 2021-03-31 13F/A-1 ISHARES TR NASDAQ BIOTECH 464287556 5,094 -770 -13.13 1 -100.00 0.0534
2021-05-11 2021-03-31 13F ISHARES TR NASDAQ BIOTECH 464287556 5,094 -770 767 0.0534
2022-07-28 2020-12-31 13F/A-1 ISHARES TR NASDAQ BIOTECH 464287556 5,864 -408 -6.51 1 -100.00 0.0658
2021-01-21 2020-12-31 13F ISHARES TR NASDAQ BIOTECH 464287556 5,864 -408 894 0.0658
2022-07-28 2020-09-30 13F/A-1 ISHARES TR NASDAQ BIOTECH 464287556 6,272 6,272 849,000 0.0737
2020-11-09 2020-09-30 13F ISHARES TR NASDAQ BIOTECH 464287556 6,272 6,272 849 0.0737
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.